Bamco Inc. NY Makes New Investment in Intuitive Surgical, Inc. $ISRG

Bamco Inc. NY purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 93,927 shares of the medical equipment provider’s stock, valued at approximately $37,353,000.

A number of other large investors also recently bought and sold shares of ISRG. Main Street Group LTD purchased a new position in shares of Intuitive Surgical during the first quarter worth $30,000. Compass Financial Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth $30,000. Laurel Wealth Advisors LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $31,000. Vermillion Wealth Management Inc. lifted its holdings in shares of Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares during the last quarter. Finally, Turning Point Benefit Group Inc. boosted its stake in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 50 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 17,283 shares of company stock worth $7,015,429. 0.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the topic of a number of analyst reports. Royal Bank Of Canada lowered their price objective on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research report on Monday, July 13th. Sanford C. Bernstein reissued an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. UBS Group began coverage on Intuitive Surgical in a research note on Tuesday, July 28th. They set a “neutral” rating and a $500.00 price objective on the stock. Mizuho set a $500.00 target price on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Finally, Leerink Partners lowered their target price on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a report on Friday, July 17th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $508.68.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $370.42 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The stock has a market capitalization of $130.86 billion, a price-to-earnings ratio of 42.43, a price-to-earnings-growth ratio of 2.69 and a beta of 1.46. The company’s fifty day moving average is $386.07 and its two-hundred day moving average is $434.03.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter last year, the company earned $1.81 EPS. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. Sell-side analysts expect that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.